206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY

Autor: Campelo, M. Díez, Caballero, J.C., Barba, M. Sánchez, Del Rey, M., Janusz, K., Lumbreras, E., Abáigar, M., Robledo, C., Jerez, A., Calderón-Cabrera, C., Such, E., Cervera, J., Sanz, G., Valcárcel, D., Hernández-Rivas, J.M., Del Cañizo, C.
Zdroj: In Leukemia Research April 2015 39 Supplement 1:S102-S103
Databáze: ScienceDirect